Prazosin for ETOH or Cocaine Craving

Stopped early · Not applicable · Has a placebo group

Conditions studied: Alcoholism, Cocaine Dependence

In brief

This double-blind placebo controlled crossover pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the placebo period are each 4 weeks in duration.

Key facts

Study ID
NCT00240227
Run by
US Department of Veterans Affairs
People needed
8
Starts
2004-04-01
Expected to finish
2009-01-01
Last updated by the study team
2018-08-31

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.